Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals
By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…
The 2014 Rho Chi Society Beta Delta Chapter Induction Ceremony
By: Tasnima Nabi, Co-Copy Editor [Content-focused] - On January 23rd, St. John’s University College of Pharmacy and Health Sciences inducted…
New Legislation Redefines Oversight for Compounding Pharmacies
By: Davidta Brown, Senior Staff Editor - As the world of healthcare and its provision evolves, laws which organize and…
Prior Experience and the Growth of the Biosimilars Market
By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…
The Status of Surveillance of Japanese Encephalitis in Asia
By: Sabrina Ahmed, PharmD Candidate c/o 2017 - One recent stride towards combating worldwide infectious disease has been in the…
Methadone Associated Arrhythmias on the Rise
By: Jenny Park, PharmD Candidate c/o 2015 - Methadone maintenance therapy is prescribed for opioid dependency. Many HIV patients who…
Dietary Supplements and Their Potential Dangers
By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…
The Importance of Organ Donation: Perspectives and the Lives Affected
By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica…
A Brave New World for Lipid Management
By: Amrita Singh, PharmD Candidate c/o 2015 - Last November, the American College of Cardiology and the American Heart Association…
ASHP 48th Midyear Clinical Meeting
By: Aleena Cherian, Co-Copy Editor [Graphics-focused] - From December 8th to 12th 2013, over 20,000 student pharmacists, residents, fellows, pharmacy…